{
    "nctId": "NCT00737009",
    "briefTitle": "An Observational Study of Adherence to Anastrozole in Early Breast Cancer Treatment",
    "officialTitle": "An Observational Study of Adherence to Adjuvant Anastrozole Therapy in Postmenopausal Patients With Early Breast Cancer Over One Year Follow-up.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 259,
    "primaryOutcomeMeasure": "To describe adherence to anastrozole treatment current practice: cases where anastrozole treatment was halted ( timescale and causes)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Postmenopausal woman with early breast cancer who are prescribed with anastrozole as adjuvant endocrine therapy under the routine clinical practice.\n* Histologically or cytologically proven to be HR+(ER or PR +)\n* No other concomitant endocrine therapy such as estrogen therapy or selective estrogen receptor modulators\n* Provision of written informed consent\n\nExclusion Criteria:\n\n* Recurrence of breast cancer\n* Known hypersensitivity to anastrozole or to any of its excipients\n* Any severe concomitant condition which makes it undesirable for the patient to participate in the trial or which would jeopardize adherence with the trial protocol: Amenorrhea\\<12 months and a intact uterus; Previous inclusion in the present study; Participation in a other clinical study during the last 30 days\u00b7\n* Women who does not agreed to participate the program",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}